A carregar...
Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial
BACKGROUND: The propagation of prions, the causative agents of Creutzfeldt-Jakob disease and other human prion diseases, requires post-translational conversion of normal cellular prion protein to disease-associated forms. The antimalarial drug quinacrine (mepacrine) prevents this conversion in vitro...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Lancet Pub. Group
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2660392/ https://ncbi.nlm.nih.gov/pubmed/19278902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(09)70049-3 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|